' // 'TESTEEEEEEEEEEEEEEEEEEE 22' ; return x; } function AbreJanela( Texto ){ // window.alert( Texto ); Janela=window.open("","Janelinha","height=200,width=400,scrollbars=yes,status=yes,left=150,screenX=150,top=150,screenY=150,resizable=yes,titlebar=yes"); Janela.document.write("
CÓDIGO | Assuntos | DEDALUS | Produção (BDPI) | Teses (BDDT) | FAPESP | ASSUNTOS | |
---|---|---|---|---|---|---|---|
CB230.2.2.4.1 | ANTIVENENOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3 | ANTÍGENOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.1 | ANTÍGENOS DE BACTÉRIAS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.2 | ANTÍGENOS DE FUNGOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.3 | ANTÍGENOS DE SUPERFÍCIE |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.3.1 | ANTÍGENOS DE HISTOCOMPATIBILIDADE |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.3.1.1 | ANTÍGENOS HLA |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.4 | ANTÍGENOS DE VÍRUS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.5 | AUTOANTÍGENOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.6 | EPITOPOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.6.1 | HAPTENOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.6X | DETERMINANTES ANTIGÊNICOS ver EPITOPOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.7 | ANTÍGENOS NUCLEARES |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.8 | SUPERANTÍGENOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.3.9 | ALÉRGENOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.4 | CITOCINAS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.4.1 | LINFOCINAS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.4.2 | INTERFERONS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.4.2.1 | INTERFERON TIPO I |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.4.2.2 | INTERFERON TIPO II |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.4.3 | QUIMIOCINAS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.4.3X | CITOCINAS QUIMIOTÁTICAS ver QUIMIOCINAS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.5 | COMPLEXO ANTÍGENO-ANTICORPO |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.5.1 | REAÇÃO CRUZADA |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.2.6 | IMUNOCOMPETÊNCIA |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.3 | PRODUTOS IMUNOLÓGICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.3.1 | VACINAS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.3.1.1 | VACINAS VIRAIS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB230.3.1.1.1 | VACINA ANTIRRÁBICA |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB240 | MICROBIOLOGIA |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Próx. Página | Menu | Pesquisar no DEDALUS | Macroestrutura |